The pipeline of cell and gene therapies advancing to commercial stages of development is growing rapidly creating a market need for GMP manufacturing expertise and capacity. The Plainville, Massachusetts viral vector manufacturing site is purpose-built for large-scale manufacturing. The state-of-the-art facility design will boast 290,000 square feet of manufacturing capacity to address growing customer needs. The Plainville site will offer a flexible and scalable configuration of laboratory and production suites co-located with adjacent warehousing and office space. An onsite engineering laboratory will support the development of turnkey production platforms enabling a rapid transition to commercial-scale operations when ready.
Learn more about the capabilities at this site by downloading our complete Site Fact Sheet.